Global Tech Reporter
SEE OTHER BRANDS

Get your daily news on science and technology

Global Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.

Press releases published on June 18, 2025

Esker Expands European Field Presence with New Office in Ghent, Belgium

Esker Expands European Field Presence with New Office in Ghent, Belgium

Press Release Esker Expands European Field Presence with New Office in Ghent, Belgium LYON, France, and MIDDLETON, Wis. — June 18, 2025 — Esker, a global cloud platform and leader in AI-driven process automation solutions for finance and customer service …

Esker breidt fysieke aanwezigheid uit met nieuw kantoor in Gent, België

Esker breidt fysieke aanwezigheid uit met nieuw kantoor in Gent, België

Press Release Esker breidt fysieke aanwezigheid uit met nieuw kantoor in Gent, België LYON, France en MIDDLETON, Wis. — 18 juni, 2025 — Esker, een wereldwijd cloudplatform en marktleider op het gebied van AI-gedreven procesautomatisering voor financiële en …

Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia

Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with Friedreich ataxia, a rare neurodegenerative disorder BRAVE study will explore the potential of omaveloxolone to address the critical unmet …

IT Teams are Losing Visibility as Tech Cost Pressures Mount, According to Flexera 2025 State of ITAM Report

IT Teams are Losing Visibility as Tech Cost Pressures Mount, According to Flexera 2025 State of ITAM Report

ITASCA, Ill., June 18, 2025 (GLOBE NEWSWIRE) -- Flexera, the global leader in technology spend and risk management, today released the Flexera 2025 State of ITAM Report, which reveals a concerning decline in complete visibility across the technology stack …

Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources

Zefiro Subsidiary Awarded USD $19.6 Million Plugging & Abandonment Management Contract from the Ohio Department of Natural Resources

FORT LAUDERDALE, Fla., June 18, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that its wholly owned subsidiary, Plants …

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock: …

Novacium lance la production industrielle de batteries haute performance intégrant son matériau d’anode à base de Silicium

Novacium lance la production industrielle de batteries haute performance intégrant son matériau d’anode à base de Silicium

MONTRÉAL et LYON, France, 18 juin 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et le développement de procédés …

Novacium Launches Industrial Production of High-Performance Batteries Incorporating Its Silicon-Based Anode Material

Novacium Launches Industrial Production of High-Performance Batteries Incorporating Its Silicon-Based Anode Material

MONTREAL and LYON, France, June 18, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is proud to …

Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML

Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML

Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer  FDA recommends inclusion of patients as young as 6 months – younger than Moleculin had proposed – to be allowed in the pediatric …

Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors

Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors

New intellectual property builds on Palvella’s multi-layered exclusivity strategy Patent term expected through at least 2038 WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage …

Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+

Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade to BB- from B+

MONTRÉAL, June 18, 2025 (GLOBE NEWSWIRE) -- Bombardier is proud that S…

Déclaration de Bart Demosky, vice-président exécutif et chef de la direction financière de Bombardier, sur la hausse de la cote de crédit de l’entreprise à BB-, auparavant à B+, par S&P Global Ratings

Déclaration de Bart Demosky, vice-président exécutif et chef de la direction financière de Bombardier, sur la hausse de la cote de crédit de l’entreprise à BB-, auparavant à B+, par S&P Global Ratings

MONTRÉAL, 18 juin 2025 (GLOBE NEWSWIRE) -- Bombardier est fière d’annoncer que S…

Dynacor Group Announces Election of Directors

Dynacor Group Announces Election of Directors

MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) -- Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the "Corporation"), is pleased to announce that at its annual general meeting of shareholders held on June 17, 2025, all nominees listed in the management proxy …

Groupe Dynacor annonce la nomination de ses administrateurs

Groupe Dynacor annonce la nomination de ses administrateurs

MONTRÉAL, 18 juin 2025 (GLOBE NEWSWIRE) -- Groupe Dynacor inc. (TSX : DNG) (« Dynacor » ou la « Société ») est heureuse d'annoncer que lors de son assemblée générale annuelle des actionnaires tenue le 17 juin 2025, tous les candidats proposés dans la …

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- F2G Ltd, a clinical-stage biopharmaceutical company developing olorofim, a novel therapy to treat life-threatening rare fungal infections with high unmet medical need, today announced the …

Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System

Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System

PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food and Drug Administration (FDA) for the development of its …

Gradient Denervation Technologies annonce son admission au programme consultatif de la FDA sur le cycle de vie complet des produits pour le développement de son système de dénervation de l’artère pulmonaire

Gradient Denervation Technologies annonce son admission au programme consultatif de la FDA sur le cycle de vie complet des produits pour le développement de son système de dénervation de l’artère pulmonaire

PARIS, 18 juin 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies annonce ce jour son admission au programme pilote TAP (Total Product Life Cycle Advisory Program, programme consultatif sur le cycle de vie complet des produits) de la Food and Drug …

Goliath Resources Closes Concurrent C$4,062,500 Non-Brokered CFT Share Financing At C$3.17 Each For Combined Gross Proceeds of C$27,065,605

Goliath Resources Closes Concurrent C$4,062,500 Non-Brokered CFT Share Financing At C$3.17 Each For Combined Gross Proceeds of C$27,065,605

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Further to its news releases dated June 2, 2025, …

Microchip Enhances Digital Signal Controller Lineup with Industry-Leading PWM Resolution and ADC Speed

Microchip Enhances Digital Signal Controller Lineup with Industry-Leading PWM Resolution and ADC Speed

CHANDLER, Ariz., June 18, 2025 (GLOBE NEWSWIRE) -- Evolving security and functional safety demands, coupled with the growing complexity of real-time embedded applications, are driving designers to seek innovative solutions that deliver greater accuracy, …

Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate

Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate

MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”) (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce that is has agreed to indicative commercial offtake terms with Aurubis AG (“Aurubis”), a leading global …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service